130 related articles for article (PubMed ID: 30951906)
21. FNDC3B promotes cell migration and tumor metastasis in hepatocellular carcinoma.
Lin CH; Lin YW; Chen YC; Liao CC; Jou YS; Hsu MT; Chen CF
Oncotarget; 2016 Aug; 7(31):49498-49508. PubMed ID: 27385217
[TBL] [Abstract][Full Text] [Related]
22. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
[TBL] [Abstract][Full Text] [Related]
23. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
[TBL] [Abstract][Full Text] [Related]
24. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma.
Ai J; Huang H; Lv X; Tang Z; Chen M; Chen T; Duan W; Sun H; Li Q; Tan R; Liu Y; Duan J; Yang Y; Wei Y; Li Y; Zhou Q
Cell Physiol Biochem; 2011; 27(3-4):207-16. PubMed ID: 21471709
[TBL] [Abstract][Full Text] [Related]
25. SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
Kohli S; Bhardwaj A; Kumari R; Das S
Cancer Res; 2018 Feb; 78(3):645-658. PubMed ID: 29217762
[TBL] [Abstract][Full Text] [Related]
26. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.
Liu W; Zeng L; Li N; Wang F; Jiang C; Guo F; Chen X; Su T; Xu C; Zhang S; Fang C
BMC Cancer; 2016 Aug; 16():584. PubMed ID: 27485544
[TBL] [Abstract][Full Text] [Related]
27. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
[TBL] [Abstract][Full Text] [Related]
28. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
Chen CY; Lin YS; Chen CL; Chao PZ; Chiou JF; Kuo CC; Lee FP; Lin YF; Sung YH; Lin YT; Li CF; Chen YJ; Chen CH
Oncotarget; 2015 Sep; 6(29):26946-59. PubMed ID: 26196246
[TBL] [Abstract][Full Text] [Related]
29. Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation.
Peverelli E; Giardino E; Vitali E; Treppiedi D; Lania AG; Mantovani G
Horm Metab Res; 2014 Nov; 46(12):845-53. PubMed ID: 25068602
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
31. The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma.
Patarat R; Riku S; Kunadirek P; Chuaypen N; Tangkijvanich P; Mutirangura A; Puttipanyalears C
Sci Rep; 2021 Jul; 11(1):14838. PubMed ID: 34290294
[TBL] [Abstract][Full Text] [Related]
32. Roles of N-terminal Annexin A2 phosphorylation sites and miR-206 in colonic adenocarcinoma.
Xiao L; Jin H; Duan W; Hou Y
Life Sci; 2020 Jul; 253():117740. PubMed ID: 32376265
[TBL] [Abstract][Full Text] [Related]
33. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
34. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.
She S; Yang M; Hu H; Hu P; Yang Y; Ren H
Cell Physiol Biochem; 2018; 45(2):744-760. PubMed ID: 29414802
[TBL] [Abstract][Full Text] [Related]
35. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
[TBL] [Abstract][Full Text] [Related]
36. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
37. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
[TBL] [Abstract][Full Text] [Related]
38. 4E-BP1
Lin X; Huang Y; Sun Y; Tan X; Ouyang J; Zhao B; Wang Y; Xing X; Liu J
Cancer Manag Res; 2020; 12():103-115. PubMed ID: 32021427
[TBL] [Abstract][Full Text] [Related]
39. UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2.
Bai DS; Wu C; Yang LX; Zhang C; Zhang PF; He YZ; Cai JB; Song ZJ; Dong ZR; Huang XY; Ke AW; Shi GM
Oncotarget; 2016 May; 7(22):32946-55. PubMed ID: 27121050
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
